The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). (2015)

First Author: Black DM
Attributed to:  CIMA: The Centre for Integrated Research into Musculoskeletal Ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/jbmr.2442

PubMed Identifier: 25545380

Publication URI: http://europepmc.org/abstract/MED/25545380

Type: Journal Article/Review

Volume: 30

Parent Publication: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Issue: 5

ISSN: 0884-0431